Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future

LaPenna, Kyle B. and Polhemus, David J. and Doiron, Jake E. and Hidalgo, Hunter A. and Li, Zhen and Lefer, David J. (2021) Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future. Antioxidants, 10 (3). p. 485. ISSN 2076-3921

[thumbnail of antioxidants-10-00485-v2.pdf] Text
antioxidants-10-00485-v2.pdf - Published Version

Download (868kB)

Abstract

Hydrogen sulfide (H2S) is an endogenous, gaseous signaling molecule that plays a critical role in cardiac and vascular biology. H2S regulates vascular tone and oxidant defenses and exerts cytoprotective effects in the heart and circulation. Recent studies indicate that H2S modulates various components of metabolic syndrome, including obesity and glucose metabolism. This review will discuss studies exhibiting H2S -derived cardioprotective signaling in heart failure with reduced ejection fraction (HFrEF). We will also discuss the role of H2S in metabolic syndrome and heart failure with preserved ejection fraction (HFpEF).

Item Type: Article
Subjects: OA Digital Library > Agricultural and Food Science
Depositing User: Unnamed user with email support@oadigitallib.org
Date Deposited: 14 Jul 2023 11:08
Last Modified: 07 Jun 2024 09:59
URI: http://library.thepustakas.com/id/eprint/1702

Actions (login required)

View Item
View Item